The present invention relates to new uses of S-2-(3-aminopropylamino)ethyl dihydrogen phosphorothioate, (amifostine) and other aminothiol compounds to treat and reverse toxicities caused by therapeutic agents, radiation treatment or diabetes. In particular, the invention provides a method for treating neurotoxicity and nephrotoxicity associated with the administration of chemotherapeutic agents.

 
Web www.patentalert.com

< Substituted thiazoles and the use thereof as inhibitors of plasminogen activator inhibitor-1

< Preparation of phosphatase inhibitors

> Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4

> Methods, systems, and computer program products for analyzing and presenting NMR lipoprotein-based risk assessment results
~ 00077